Skip to main content
. 2017 May 23;7:2256. doi: 10.1038/s41598-017-02256-4

Figure 2.

Figure 2

Effect of sFRP4 on CSC cell surface markers: Using Immunofluorescence, CD44+/CD24/CD133+/Ki67/ABCG2 were detected in all the tumor cell line-derived CSCs. sFRP4 in combination with doxorubicin/cisplatin showed disruption of the spheres. Nuclei were counterstained with Hoechst 33342 (blue). (a,b) CD44+/CD24 breast tumor cell line CSCs (MDA231/MCF7). (c,d) Prostate tumor cell line derived CSCs. PC3 expressed CD44+/CD133+/Ki67/ABCG2. LnCap was negative for CD44+. (e–g) CD44+/CD133+/Ki67/ABCG2 observed in ovary tumor cell line-derived CSCs (A2780 P/CIS/ADR). Immunofluorescence images are representative from 3 independent experiments. (Scale bar: 100 μm).